✦ LIBER ✦

Cardiac Safety in Clinical Trials of Phosphodiesterase 5 Inhibitors

✍ Scribed by Culley C. Carson III

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cardiac Uses of Phosphodiesterase-5 Inhi

✍ Bryan G. Schwartz; Laurence A. Levine; Gary Comstock; Vera J. Stecher; Robert A. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 265 KB

Clinical Use of Phosphodiesterase-5 Inhi

✍ Guazzi, M. 📂 Article 📅 2008 🏛 Ovid Technologies Wolters Kluwer -American Heart A 🌐 English ⚖ 189 KB

Cardiac Role of Cyclic-GMP Hydrolyzing P

✍ David A. Kass 📂 Article 📅 2012 🏛 Current Science Inc. 🌐 English ⚖ 246 KB

Evaluating Preference Trials of Oral Pho

✍ John P. Mulhall; Francesco Montorsi 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 146 KB

The Clinical Pharmacokinetics of Phospho

✍ Gupta, Manish; Kovar, Andreas; Meibohm, Bernd 📂 Article 📅 2005 🏛 Sage Publications 🌐 English ⚖ 237 KB

Effectiveness and Safety of Phosphodiest

✍ Chrysant, Steven G. 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 224 KB